Home » Topics » BioWorld Science

BioWorld Science
RSS

BenevolentAI Bio patents tyrosine-protein kinase ABL1 inhibitors

April 6, 2021

New IRAK-4 inhibitors discovered at Shanghai Institute of Materia Medica

April 6, 2021

Roche identifies new MAGL inhibitors

April 6, 2021

Biotheus describes antibodies targeting carbonic anhydrase IX

April 6, 2021

Positive phase I/II data for VLA-2001 COVID-19 vaccine candidate

April 6, 2021

Initial clinical data from phase I/II SWORD-1 study of TPX-0046

April 6, 2021

DMC approves increased dosing frequency in phase II study of Brilacidin for COVID-19

April 6, 2021

GPR68 targeting is protective against ischemic stroke in mice

April 6, 2021

VIR-7831 maintains neutralizing activity against SARS-CoV-2 California variant

April 6, 2021

Safety cohort data from phase II study of prexigebersen plus frontline therapies for AML

April 6, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...